Mentioned on:
Discover the fastest growing tech startups around the world.
Discover the most active investors around the world.
By Industry
By City
By Country
By Continent
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
2
Funding Rounds
$177.0m
Money raised
The company GentiBio has raised a total of $177m in funding over 2 rounds.